Therapy and prognostic factors in adult acute lymphoblastic leukaemia (Q40558227)

21 September 2017

1 reference

title

Therapy and prognostic factors in adult acute lymphoblastic leukaemia (English)

1 reference

21 September 2017

1 reference

Hoelzer D

1

1 reference

21 September 2017

publication date

1 June 1994

1 reference

Best Practice and Research: Clinical Haematology

21 September 2017

published in

1 reference

21 September 2017

volume

7

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

299-320

1 reference

E-rosette positive acute lymphoblastic leukaemia in adolescents and adults

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Remission induction of meningeal leukemia with high-dose intravenous methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Treatment of acute lymphoblastic leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Prognostic Value of Immunologic Markers in Adults with Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Clinical relevance of cytogenetics in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Current status of ALL/AUL therapy in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Improved results of an intensified therapy in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

mdr-1 gene amplification in acute lymphoblastic leukaemia prior to antileukaemic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Chemotherapy of adult acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980204-5

7 January 2021

10.1016/S0950-3536(05)80204-5

Identifiers

DOI

1 reference

21 September 2017

1 reference